Calcitonin Gene-Related Peptide and Adrenomedullin Levels During Ictal and Interictal Periods in Patients With Migraine

Background Peptides related to calcitonin gene-related peptide (CGRP) have been suggested to have a role in migraine. Adrenomedullin (AM) might be a candidate molecule because it is related to pain pathways in the peripheral and central nervous systems and uses the same receptors as CGRP. Methodolog...

Full description

Saved in:
Bibliographic Details
Published inCurēus (Palo Alto, CA) Vol. 15; no. 4; p. e37843
Main Authors Neyal, Abdurrahman, Ekmekyapar Fırat, Yasemin, Çekmen, Mustafa B, Kılıçparlar Cengiz, Emine, Koç Ada, Saniye, Neyal, Ayşe M
Format Journal Article
LanguageEnglish
Published United States Springer Nature B.V 19.04.2023
Cureus
Subjects
Online AccessGet full text
ISSN2168-8184
2168-8184
DOI10.7759/cureus.37843

Cover

Abstract Background Peptides related to calcitonin gene-related peptide (CGRP) have been suggested to have a role in migraine. Adrenomedullin (AM) might be a candidate molecule because it is related to pain pathways in the peripheral and central nervous systems and uses the same receptors as CGRP. Methodology In this study, we examined the serum CGRP and AM levels during unprovoked ictal and interictal periods of 30 migraine patients as well as 25 healthy controls. Another focus of this study was on the association of CGRP and AM levels with clinical features. Results Mean serum AM levels were 15.80 pg/mL (11.91-21.43 pg/mL) in the ictal and 15.85 pg/mL (12.25-19.29 pg/mL) in the interictal periods in the migraine group and 13.36 pg/mL (10.84-17.18 pg/mL) in the control group. Mean serum CGRP levels were 2.93 pg/mL (2.45-3.90 pg/mL) in the ictal and 3.25 pg/mL (2.85-4.67 pg/mL) in the interictal periods in the migraine group and 3.03 pg/mL (2.48-3.80 pg/mL) in the control group. There were no statistical differences between ictal and/or interictal AM and CGRP levels (p = 0.558 and p = 0.054, respectively) which were also comparable with the results of the control group (p = 0.230, p = 0.295, p = 0.987, p = 0.139, respectively). Ictal serum CGRP and/or AM levels did not correlate with any of the reported clinical features. Conclusions Serum AM and CGRP levels are similar in interictal and unprovoked ictal periods in migraine patients and as well in controls. These results do not indicate that these molecules do not have a role in migraine pathophysiology. Considering the broad mechanisms of action of peptides in the CGRP family, further studies are needed in larger cohorts.
AbstractList Background Peptides related to calcitonin gene-related peptide (CGRP) have been suggested to have a role in migraine. Adrenomedullin (AM) might be a candidate molecule because it is related to pain pathways in the peripheral and central nervous systems and uses the same receptors as CGRP. Methodology In this study, we examined the serum CGRP and AM levels during unprovoked ictal and interictal periods of 30 migraine patients as well as 25 healthy controls. Another focus of this study was on the association of CGRP and AM levels with clinical features. Results Mean serum AM levels were 15.80 pg/mL (11.91-21.43 pg/mL) in the ictal and 15.85 pg/mL (12.25-19.29 pg/mL) in the interictal periods in the migraine group and 13.36 pg/mL (10.84-17.18 pg/mL) in the control group. Mean serum CGRP levels were 2.93 pg/mL (2.45-3.90 pg/mL) in the ictal and 3.25 pg/mL (2.85-4.67 pg/mL) in the interictal periods in the migraine group and 3.03 pg/mL (2.48-3.80 pg/mL) in the control group. There were no statistical differences between ictal and/or interictal AM and CGRP levels (p = 0.558 and p = 0.054, respectively) which were also comparable with the results of the control group (p = 0.230, p = 0.295, p = 0.987, p = 0.139, respectively). Ictal serum CGRP and/or AM levels did not correlate with any of the reported clinical features. Conclusions Serum AM and CGRP levels are similar in interictal and unprovoked ictal periods in migraine patients and as well in controls. These results do not indicate that these molecules do not have a role in migraine pathophysiology. Considering the broad mechanisms of action of peptides in the CGRP family, further studies are needed in larger cohorts.
Background Peptides related to calcitonin gene-related peptide (CGRP) have been suggested to have a role in migraine. Adrenomedullin (AM) might be a candidate molecule because it is related to pain pathways in the peripheral and central nervous systems and uses the same receptors as CGRP. Methodology In this study, we examined the serum CGRP and AM levels during unprovoked ictal and interictal periods of 30 migraine patients as well as 25 healthy controls. Another focus of this study was on the association of CGRP and AM levels with clinical features. Results Mean serum AM levels were 15.80 pg/mL (11.91-21.43 pg/mL) in the ictal and 15.85 pg/mL (12.25-19.29 pg/mL) in the interictal periods in the migraine group and 13.36 pg/mL (10.84-17.18 pg/mL) in the control group. Mean serum CGRP levels were 2.93 pg/mL (2.45-3.90 pg/mL) in the ictal and 3.25 pg/mL (2.85-4.67 pg/mL) in the interictal periods in the migraine group and 3.03 pg/mL (2.48-3.80 pg/mL) in the control group. There were no statistical differences between ictal and/or interictal AM and CGRP levels (p = 0.558 and p = 0.054, respectively) which were also comparable with the results of the control group (p = 0.230, p = 0.295, p = 0.987, p = 0.139, respectively). Ictal serum CGRP and/or AM levels did not correlate with any of the reported clinical features. Conclusions Serum AM and CGRP levels are similar in interictal and unprovoked ictal periods in migraine patients and as well in controls. These results do not indicate that these molecules do not have a role in migraine pathophysiology. Considering the broad mechanisms of action of peptides in the CGRP family, further studies are needed in larger cohorts.Background Peptides related to calcitonin gene-related peptide (CGRP) have been suggested to have a role in migraine. Adrenomedullin (AM) might be a candidate molecule because it is related to pain pathways in the peripheral and central nervous systems and uses the same receptors as CGRP. Methodology In this study, we examined the serum CGRP and AM levels during unprovoked ictal and interictal periods of 30 migraine patients as well as 25 healthy controls. Another focus of this study was on the association of CGRP and AM levels with clinical features. Results Mean serum AM levels were 15.80 pg/mL (11.91-21.43 pg/mL) in the ictal and 15.85 pg/mL (12.25-19.29 pg/mL) in the interictal periods in the migraine group and 13.36 pg/mL (10.84-17.18 pg/mL) in the control group. Mean serum CGRP levels were 2.93 pg/mL (2.45-3.90 pg/mL) in the ictal and 3.25 pg/mL (2.85-4.67 pg/mL) in the interictal periods in the migraine group and 3.03 pg/mL (2.48-3.80 pg/mL) in the control group. There were no statistical differences between ictal and/or interictal AM and CGRP levels (p = 0.558 and p = 0.054, respectively) which were also comparable with the results of the control group (p = 0.230, p = 0.295, p = 0.987, p = 0.139, respectively). Ictal serum CGRP and/or AM levels did not correlate with any of the reported clinical features. Conclusions Serum AM and CGRP levels are similar in interictal and unprovoked ictal periods in migraine patients and as well in controls. These results do not indicate that these molecules do not have a role in migraine pathophysiology. Considering the broad mechanisms of action of peptides in the CGRP family, further studies are needed in larger cohorts.
BackgroundPeptides related to calcitonin gene-related peptide (CGRP) have been suggested to have a role in migraine. Adrenomedullin (AM) might be a candidate molecule because it is related to pain pathways in the peripheral and central nervous systems and uses the same receptors as CGRP.MethodologyIn this study, we examined the serum CGRP and AM levels during unprovoked ictal and interictal periods of 30 migraine patients as well as 25 healthy controls. Another focus of this study was on the association of CGRP and AM levels with clinical features.ResultsMean serum AM levels were 15.80 pg/mL (11.91-21.43 pg/mL) in the ictal and 15.85 pg/mL (12.25-19.29 pg/mL) in the interictal periods in the migraine group and 13.36 pg/mL (10.84-17.18 pg/mL) in the control group. Mean serum CGRP levels were 2.93 pg/mL (2.45-3.90 pg/mL) in the ictal and 3.25 pg/mL (2.85-4.67 pg/mL) in the interictal periods in the migraine group and 3.03 pg/mL (2.48-3.80 pg/mL) in the control group. There were no statistical differences between ictal and/or interictal AM and CGRP levels (p = 0.558 and p = 0.054, respectively) which were also comparable with the results of the control group (p = 0.230, p = 0.295, p = 0.987, p = 0.139, respectively). Ictal serum CGRP and/or AM levels did not correlate with any of the reported clinical features.ConclusionsSerum AM and CGRP levels are similar in interictal and unprovoked ictal periods in migraine patients and as well in controls. These results do not indicate that these molecules do not have a role in migraine pathophysiology. Considering the broad mechanisms of action of peptides in the CGRP family, further studies are needed in larger cohorts.
Author Neyal, Abdurrahman
Neyal, Ayşe M
Koç Ada, Saniye
Ekmekyapar Fırat, Yasemin
Çekmen, Mustafa B
Kılıçparlar Cengiz, Emine
AuthorAffiliation 3 Department of Medical Biochemistry, Istanbul Medeniyet University School of Medicine, Istanbul, TUR
4 Department of Neurology, Dr. Ersin Arslan Education and Research Hospital, Gaziantep, TUR
1 Department of Neurology, Gaziantep Islam Science and Technology University School of Medicine, Gaziantep, TUR
2 Department of Neurology, Sanko University School of Medicine, Gaziantep, TUR
AuthorAffiliation_xml – name: 2 Department of Neurology, Sanko University School of Medicine, Gaziantep, TUR
– name: 1 Department of Neurology, Gaziantep Islam Science and Technology University School of Medicine, Gaziantep, TUR
– name: 3 Department of Medical Biochemistry, Istanbul Medeniyet University School of Medicine, Istanbul, TUR
– name: 4 Department of Neurology, Dr. Ersin Arslan Education and Research Hospital, Gaziantep, TUR
Author_xml – sequence: 1
  givenname: Abdurrahman
  surname: Neyal
  fullname: Neyal, Abdurrahman
– sequence: 2
  givenname: Yasemin
  surname: Ekmekyapar Fırat
  fullname: Ekmekyapar Fırat, Yasemin
– sequence: 3
  givenname: Mustafa B
  surname: Çekmen
  fullname: Çekmen, Mustafa B
– sequence: 4
  givenname: Emine
  surname: Kılıçparlar Cengiz
  fullname: Kılıçparlar Cengiz, Emine
– sequence: 5
  givenname: Saniye
  surname: Koç Ada
  fullname: Koç Ada, Saniye
– sequence: 6
  givenname: Ayşe M
  surname: Neyal
  fullname: Neyal, Ayşe M
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37214082$$D View this record in MEDLINE/PubMed
BookMark eNqFkkFvEzEQhS1UREvpjTOyxIUDW2zvOvaeUBWgRAoiQiCOq1nvbOrKsYPtbdV_j5sUKBUSJ4_lb97MvPFTcuCDR0Kec3aqlGzfmCnilE5rpZv6ETkSfKYrzXVzcC8-JCcpXTLGOFOCKfaEHNZK8IZpcUSu5-CMzcFbT8_RY_UFHWQc6Aq32Q5IwQ_0bIjowwaHybnCLfEKXaLvpmj9mi5MBrfDFj5jtLvrqgRhSLTQK8gWfU70u80X9JNdR7Aen5HHI7iEJ3fnMfn24f3X-cdq-fl8MT9bVqZu6lypRkoDtTFSq7GdmbaZYY-CNUILIdk4gmlHBGwlHwcloG9RNBwU64cResnqY1LtdSe_hZtrcK7bRruBeNNx1t162O097HYeFv7tnt9OfRnYlM4j_MkJYLu_X7y96NbhqqjxVksti8KrO4UYfkyYcrexyaBz4DGUOkJzpVTLpS7oywfoZZiiL34USnChRK3aQr2439LvXn4tsQCv94CJIaWI4_9GFA_w8gHKksLtQNb9O-knzLzDtQ
CitedBy_id crossref_primary_10_1186_s10194_024_01769_4
Cites_doi 10.1111/bph.15605
10.3389/fneur.2022.930383
10.1007/s40263-021-00834-9
10.1186/s10194-022-01464-2
10.1177/0333102417738202
10.1111/head.13802
10.1186/s12916-015-0522-1
10.1242/jcs.02783
10.1177/03331024211018137
10.1002/ana.410280213
10.1007/s10072-022-06199-1
10.1210/edrv.21.2.0396
10.1136/jnnp.2009.190223
10.3389/fpain.2022.873179
10.1016/j.bbrc.2012.08.022
10.1002/ana.20605
10.1212/WNL.0000000000011930
10.1002/ana.26072
10.1111/j.1468-2982.2008.01695.x
10.1111/head.14388
10.1111/bph.12129
10.1186/s12883-020-01633-3
10.1007/s12031-020-01493-z
10.1007/164_2018_173
10.4103/1673-5374.272567
10.1097/WCO.0000000000000440
10.1007/s11916-014-0458-8
10.1210/en.2010-0121
10.1111/head.13510
10.1186/s10194-022-01472-2
ContentType Journal Article
Copyright Copyright © 2023, Neyal et al.
Copyright © 2023, Neyal et al. This work is published under https://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright © 2023, Neyal et al. 2023 Neyal et al.
Copyright_xml – notice: Copyright © 2023, Neyal et al.
– notice: Copyright © 2023, Neyal et al. This work is published under https://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Copyright © 2023, Neyal et al. 2023 Neyal et al.
DBID AAYXX
CITATION
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
5PM
ADTOC
UNPAY
DOI 10.7759/cureus.37843
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest One Health & Nursing
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
ProQuest Health & Medical Research Collection
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
Publicly Available Content Database
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2168-8184
ExternalDocumentID 10.7759/cureus.37843
PMC10198585
37214082
10_7759_cureus_37843
Genre Journal Article
GroupedDBID 53G
5VS
7X7
8FI
8FJ
AAYXX
ABUWG
ADBBV
AFKRA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
CITATION
FYUFA
HMCUK
HYE
KQ8
M48
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PUEGO
RPM
UKHRP
3V.
ADRAZ
ALIPV
GROUPED_DOAJ
NPM
OK1
7XB
8FK
AZQEC
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
7X8
5PM
ADTOC
UNPAY
ID FETCH-LOGICAL-c343t-7455ca3cc587f96c946ebe204282250ffac9feae951fd72ab9e241a70bdfab503
IEDL.DBID UNPAY
ISSN 2168-8184
IngestDate Sun Oct 26 03:51:17 EDT 2025
Tue Sep 30 17:14:23 EDT 2025
Fri Sep 05 12:02:35 EDT 2025
Tue Oct 07 07:16:37 EDT 2025
Thu Jan 02 22:39:30 EST 2025
Wed Oct 01 02:02:34 EDT 2025
Thu Apr 24 22:59:27 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords ictal period
adrenomedullin
migraine
interictal period
cgrp
Language English
License Copyright © 2023, Neyal et al.
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
cc-by
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c343t-7455ca3cc587f96c946ebe204282250ffac9feae951fd72ab9e241a70bdfab503
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://proxy.k.utb.cz/login?url=https://assets.cureus.com/uploads/original_article/pdf/145764/20230419-20204-mpnhoc.pdf
PMID 37214082
PQID 2821272379
PQPubID 2045583
ParticipantIDs unpaywall_primary_10_7759_cureus_37843
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10198585
proquest_miscellaneous_2817779158
proquest_journals_2821272379
pubmed_primary_37214082
crossref_primary_10_7759_cureus_37843
crossref_citationtrail_10_7759_cureus_37843
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-04-19
PublicationDateYYYYMMDD 2023-04-19
PublicationDate_xml – month: 04
  year: 2023
  text: 2023-04-19
  day: 19
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Palo Alto
– name: Palo Alto (CA)
PublicationTitle Curēus (Palo Alto, CA)
PublicationTitleAlternate Cureus
PublicationYear 2023
Publisher Springer Nature B.V
Cureus
Publisher_xml – name: Springer Nature B.V
– name: Cureus
References Hinson JP (ref12) 2000; 21
Garelja ML (ref10) 2022; 62
(ref20) 2018; 38
Wang X (ref4) 2022; 23
Ramón C (ref25) 2017; 30
Walker CS (ref26) 2013; 170
Johnson B (ref30) 2022; 3
Li FJ (ref13) 2020; 15
Edvinsson L (ref28) 2020; 70
Mitsikostas DD (ref5) 2015; 13
Frank F (ref8) 2021; 41
Overeem LH (ref9) 2021; 35
Boulloche N (ref17) 2010; 81
Ghanizada H (ref16) 2021; 96
Rees TA (ref1) 2022; 179
Nikitenko LL (ref29) 2006; 119
Frederiksen SD (ref23) 2020; 60
Mascarella D (ref6) 2022; 43
Kitamura K (ref11) 2012; 425
Kamm K (ref24) 2022; 13
Hargreaves R (ref2) 2019; 59
Rujan RM (ref7) 2019; 255
Fernández AP (ref14) 2010; 151
Petersen KA (ref15) 2009; 29
Deng H (ref3) 2020; 20
Harriott AM (ref18) 2014; 18
Goadsby PJ (ref21) 1990; 28
Ghanizada H (ref27) 2021; 89
Ashina H (ref19) 2022; 23
Tvedskov JF (ref22) 2005; 58
References_xml – volume: 179
  year: 2022
  ident: ref1
  article-title: Beyond CGRP: the calcitonin peptide family as targets for migraine and pain
  publication-title: Br J Pharmacol
  doi: 10.1111/bph.15605
– volume: 13
  year: 2022
  ident: ref24
  article-title: CGRP and migraine: what have we learned from measuring CGRP in migraine patients so far?
  publication-title: Front Neurol
  doi: 10.3389/fneur.2022.930383
– volume: 35
  year: 2021
  ident: ref9
  article-title: Indirect comparison of topiramate and monoclonal antibodies against CGRP or its receptor for the prophylaxis of episodic migraine: a systematic review with meta-analysis
  publication-title: CNS Drugs
  doi: 10.1007/s40263-021-00834-9
– volume: 23
  year: 2022
  ident: ref19
  article-title: Provoked versus spontaneous migraine attacks: pathophysiological similarities and differences
  publication-title: J Headache Pain
  doi: 10.1186/s10194-022-01464-2
– volume: 38
  year: 2018
  ident: ref20
  article-title: Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
  publication-title: Cephalalgia
  doi: 10.1177/0333102417738202
– volume: 60
  year: 2020
  ident: ref23
  article-title: Serotonin and neuropeptides in blood from episodic and chronic migraine and cluster headache patients in case-control and case-crossover settings: a systematic review and meta-analysis
  publication-title: Headache
  doi: 10.1111/head.13802
– volume: 13
  year: 2015
  ident: ref5
  article-title: New players in the preventive treatment of migraine
  publication-title: BMC Med
  doi: 10.1186/s12916-015-0522-1
– volume: 119
  year: 2006
  ident: ref29
  article-title: Adrenomedullin and CGRP interact with endogenous calcitonin-receptor-like receptor in endothelial cells and induce its desensitisation by different mechanisms
  publication-title: J Cell Sci
  doi: 10.1242/jcs.02783
– volume: 41
  year: 2021
  ident: ref8
  article-title: CGRP-antibodies, topiramate and botulinum toxin type A in episodic and chronic migraine: a systematic review and meta-analysis
  publication-title: Cephalalgia
  doi: 10.1177/03331024211018137
– volume: 28
  year: 1990
  ident: ref21
  article-title: Vasoactive peptide release in the extracerebral circulation of humans during migraine headache
  publication-title: Ann Neurol
  doi: 10.1002/ana.410280213
– volume: 43
  year: 2022
  ident: ref6
  article-title: The ultimate guide to the anti-CGRP monoclonal antibodies galaxy
  publication-title: Neurol Sci
  doi: 10.1007/s10072-022-06199-1
– volume: 21
  year: 2000
  ident: ref12
  article-title: Adrenomedullin, a multifunctional regulatory peptide
  publication-title: Endocr Rev
  doi: 10.1210/edrv.21.2.0396
– volume: 81
  year: 2010
  ident: ref17
  article-title: Photophobia in migraine: an interictal PET study of cortical hyperexcitability and its modulation by pain
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp.2009.190223
– volume: 3
  year: 2022
  ident: ref30
  article-title: New approaches to shifting the migraine treatment paradigm
  publication-title: Front Pain Res (Lausanne)
  doi: 10.3389/fpain.2022.873179
– volume: 425
  year: 2012
  ident: ref11
  article-title: Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. 1993
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2012.08.022
– volume: 58
  year: 2005
  ident: ref22
  article-title: No increase of calcitonin gene-related peptide in jugular blood during migraine
  publication-title: Ann Neurol
  doi: 10.1002/ana.20605
– volume: 96
  year: 2021
  ident: ref16
  article-title: Effect of adrenomedullin on migraine-like attacks in patients with migraine: a randomized crossover study
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000011930
– volume: 89
  year: 2021
  ident: ref27
  article-title: Amylin analog pramlintide induces migraine-like attacks in patients
  publication-title: Ann Neurol
  doi: 10.1002/ana.26072
– volume: 29
  year: 2009
  ident: ref15
  article-title: Effect of adrenomedullin on the cerebral circulation: relevance to primary headache disorders
  publication-title: Cephalalgia
  doi: 10.1111/j.1468-2982.2008.01695.x
– volume: 62
  year: 2022
  ident: ref10
  article-title: A narrative review of the calcitonin peptide family and associated receptors as migraine targets: calcitonin gene-related peptide and beyond
  publication-title: Headache
  doi: 10.1111/head.14388
– volume: 170
  year: 2013
  ident: ref26
  article-title: CGRP in the trigeminovascular system: a role for CGRP, adrenomedullin and amylin receptors?
  publication-title: Br J Pharmacol
  doi: 10.1111/bph.12129
– volume: 20
  year: 2020
  ident: ref3
  article-title: Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine - an updated systematic review and meta-analysis
  publication-title: BMC Neurol
  doi: 10.1186/s12883-020-01633-3
– volume: 70
  year: 2020
  ident: ref28
  article-title: Expression of the CGRP family of neuropeptides and their receptors in the trigeminal ganglion
  publication-title: J Mol Neurosci
  doi: 10.1007/s12031-020-01493-z
– volume: 255
  year: 2019
  ident: ref7
  article-title: Calcitonin gene-related peptide antagonists and therapeutic antibodies
  publication-title: Handb Exp Pharmacol
  doi: 10.1007/164_2018_173
– volume: 15
  year: 2020
  ident: ref13
  article-title: Adrenomedullin: an important participant in neurological diseases
  publication-title: Neural Regen Res
  doi: 10.4103/1673-5374.272567
– volume: 30
  year: 2017
  ident: ref25
  article-title: Calcitonin gene-related peptide in peripheral blood as a biomarker for migraine
  publication-title: Curr Opin Neurol
  doi: 10.1097/WCO.0000000000000440
– volume: 18
  year: 2014
  ident: ref18
  article-title: Migraine is associated with altered processing of sensory stimuli
  publication-title: Curr Pain Headache Rep
  doi: 10.1007/s11916-014-0458-8
– volume: 151
  year: 2010
  ident: ref14
  article-title: Lack of adrenomedullin in the central nervous system results in apparently paradoxical alterations on pain sensitivity
  publication-title: Endocrinology
  doi: 10.1210/en.2010-0121
– volume: 59
  year: 2019
  ident: ref2
  article-title: Calcitonin gene-related peptide modulators - the history and renaissance of a new migraine drug class
  publication-title: Headache
  doi: 10.1111/head.13510
– volume: 23
  year: 2022
  ident: ref4
  article-title: Efficacy and safety of monoclonal antibody against calcitonin gene-related peptide or its receptor for migraine patients with prior preventive treatment failure: a network meta-analysis
  publication-title: J Headache Pain
  doi: 10.1186/s10194-022-01472-2
SSID ssj0001072070
Score 2.2334597
Snippet Background Peptides related to calcitonin gene-related peptide (CGRP) have been suggested to have a role in migraine. Adrenomedullin (AM) might be a candidate...
BackgroundPeptides related to calcitonin gene-related peptide (CGRP) have been suggested to have a role in migraine. Adrenomedullin (AM) might be a candidate...
SourceID unpaywall
pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e37843
SubjectTerms Headaches
Laboratories
Males
Migraine
Neurology
Outpatient care facilities
Pathophysiology
Patients
Peptides
Physiology
Statistical analysis
SummonAdditionalLinks – databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEB_qFdSX4mdNrbKC-iKxSTa5TR5Eam2p4h2HWOxb2E8bOPbO5kLxv3cmH1ePYt8SdiBsfjM7MztfAK-NEYorJcM81lmYJlaE0kUqVNYYZVOR25jqnSfT8elZ-vU8O9-C6VALQ2mVw5nYHtRmoemO_ABdgzgRCRfFx-XvkKZGUXR1GKEh-9EK5kPbYuwObCfUGWsE25-Op7Pv17cukUiQybsMeCGy4kA3l7ap33ORp3xTN90wOG_mTd5r_FL-uZLz-T9K6eQB7PTWJDvs4H8IW9Y_gruTPl7-GK6O5FyjzPrKM2owHba5b9awGSWzGMukN-yQirmpCJ_iQp59ozSimn1u6xfZF43WeUvW3h1W7esMHxamZkg96_qy1uxntbpgk-oXjZywT-Ds5PjH0WnYj1oINU_5KhRplmnJtc5y4YqxLtIxopuQQ4UCHzkndeGstGiPOSMSqQqLql-KSBknVRbxpzDyC2-fAXOpytCtdi7iNkX7R0q0uVDncYeIiDwL4N3wk0vd9yGncRjzEv0RgqTsIClbSAJ4s6Zedv03_kO3P-BV9lJYl9c8E8Cr9TLKDwVFpLeLhmhiIUQRZ3kAux286w9xdI9pIHcA-QbwawLqzb254quLtkc3nnQFhVwDeLvmkVs3sHf7Bp7DfRp0T3GsuNiH0eqysS_QHFqplz2P_wXzThDq
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9NAEF6VIgGXijeGghYJekEOtteb9Z5QVagKIigHInqz9kktWU6axGr775lZOxZRAHGz5ZG93tnHNzuPj5A31grNtFZxkRoe55kTsfKJjrWzVrtcFC7FfOfJt_HZLP9yzs_3yCZ-vu_A1R9NO-STmi3r0fXlzQeY8IBfR0Jw-d60S9euRkwUOTtaXMZIKYWu155f4xa5DduWRF6HSY_9wwFMIrIkkMll6biAthZ5Fxi_887tLWsHh-6GU95tm4W6uVJ1_dtedXqfHPQgkx53o-IB2XPNQ3Jn0rvRH5GrE1UbmMpN1VCsOx2HkDhn6RRjXKyjqrH0GHO8MTcf3UUN_YrRRSv6MaQ10s8G-iuIhSPFKtxO4WJuVxSkp1251hX9Ua0v6KT6iUwU7jGZnX76fnIW9wwMsWE5W8ci59woZgwvhJdjI_MxKD1DOwvWgcR7ZaR3ygFM81ZkSksHiECJRFuvNE_YE7LfzBv3jFCfaw7WtvcJcznAIqUAisFWyHwKVlHBI_Ju08ml6cuTI0tGXYKZgiopO5WUQSUReTtIL7qyHH-RO9zoq9yMrRIan2YiY0JG5PXwGKYV-kpU4-YtyqRCCJnyIiJPO_UOH2JgNSNPd0SKLcUPAliye_tJU12E0t2wAEr0xEbkaBgj__yB5__RwhfkXgbQC31cqTwk--tl614CVFrrV2HI_wIBQhka
  priority: 102
  providerName: Scholars Portal
Title Calcitonin Gene-Related Peptide and Adrenomedullin Levels During Ictal and Interictal Periods in Patients With Migraine
URI https://www.ncbi.nlm.nih.gov/pubmed/37214082
https://www.proquest.com/docview/2821272379
https://www.proquest.com/docview/2817779158
https://pubmed.ncbi.nlm.nih.gov/PMC10198585
https://assets.cureus.com/uploads/original_article/pdf/145764/20230419-20204-mpnhoc.pdf
UnpaywallVersion publishedVersion
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 2168-8184
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001072070
  issn: 2168-8184
  databaseCode: KQ8
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 2168-8184
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001072070
  issn: 2168-8184
  databaseCode: KQ8
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 2168-8184
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001072070
  issn: 2168-8184
  databaseCode: RPM
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVPQU
  databaseName: Health & Medical Collection (ProQuest)
  customDbUrl:
  eissn: 2168-8184
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001072070
  issn: 2168-8184
  databaseCode: 7X7
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 2168-8184
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001072070
  issn: 2168-8184
  databaseCode: BENPR
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 2168-8184
  dateEnd: 20250930
  omitProxy: true
  ssIdentifier: ssj0001072070
  issn: 2168-8184
  databaseCode: M48
  dateStart: 20121101
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lj9MwEB7tthJw4f0ILJWRgAtKm8ROnRzLsqsF0apCVFtOkZ80oqTVNtECv55xklaUFYgLt1iZyK-x_U1m_A3Ac625pFIKPwlV7LPIcF_YQPrSaC0N44kJ3X3n8WR4NmPv5vH8AM63d2EQMZoSR7u6MFVL_7deroTeDLaJorJ2SAdrbQchQ7zMnAWPZnmY4pxHAfO_rovFSvVR4BC6wxhBege6s8l09MmlmguHCbYsYU0YPOdxOmirozxhdP-AuoI6rwZPXq-Ktfh-KZbLX06m01vwbdunJiDlS78qZV_9-I3u8T90-jbcbNEsGTWf3YEDU9yFa-PWX38PLo_FUuGeUeQFcQTXfh17ZzSZumAabYgoNBm5y-SOBMD5pQry3oUxbcib-v4keavQOqjF6n-XeV2c4sNKbwhKTxte2A05z8sFGeefXcoLcx9mpycfj8_8NtWDryijpc9ZHCtBlYoTbtOhStkQtStyBh1uOIG1QqXWCIN40GoeCZkahB6CB1JbIeOAPoBOsSrMIyCWyRjNemsDahjiLyEQ8-GZS22I5lcSe_BqO7-ZannQXTqOZYb2kNOGrJmHrNYGD17spNcN_8cf5I62qpK1u8Amw8aHEY8oTz14tnuN69c5ZURhVpWTCTnnaRgnHjxsNGtXEUXz3CUE9yDZ07mdgOMG339T5IuaIxx32tS5fD14uVPPv3bg8b8KPoEbTvOcRy1Mj6BTXlTmKQKzUvbgkM95D7qvTybTD1gas6TXLryfbrxDHw
linkProvider Unpaywall
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VVqJcKt64FFgkygWZ2t511j5UqPShhCZRhFrRm9knjRQ5oY4V9c_x25i1HZeoorfebO3I1u7M7M638wL4oDWXVErhJ6GKfRYZ7gsbSF8araVhPDGhy3ceDDvdc_btIr5Ygz_LXBgXVrncE6uNWk-VuyPfQ2gQRjyiPP0y--27rlHOu7psoSGa1gp6vyox1iR2nJrrBUK4Yr93hPzejaKT47PDrt90GfAVZXTucxbHSlCl4oTbtKNS1sGJRQ5LoKwH1gqVWiMMmiJW80jI1OCpJ3ggtRUyDih-9wFsMMpSBH8bX4-Ho-83tzwBj1Cp6oh7zuN0T5VXpiw-U54wunoW3jJwb8dpbpb5TFwvxGTyzyF48hi2GuuVHNTi9gTWTP4UHg4a__wzWByKicI9Ih_nxBW09qtYO6PJyAXPaENErsmBSx53Sf_OD5WTvgtbKshRlS9JegrRQEVW3VWOq9cRPkx1QZB6VNeBLciP8fySDMa_XIsL8xzO72XRX8B6Ps3NKyCWyRhhvLUBNQztLSHQxsMzltoQ4VYSe_BpuciZauqeu_Ybkwzxj2NJVrMkq1jiwW5LPavrffyHbmfJr6zR-iK7kVEP3rfDqK_OCSNyMy0dTcg5T8M48eBlzd72RxThuGsA7kGywviWwNUCXx3Jx5dVTXDcWVPn4vXgYysjd05g--4JvIPN7tmgn_V7w9PX8ChC08750MJ0B9bnV6V5g6bYXL5t5J3Az_tWsb9PsU8m
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtNAcFSKVLgg3rgUWCTKBZnYXjtrHxCqGqKGNlUOVORm9kktRU5aJ4r6a3wdM7aTElX01putHdnanffOC-CDMUJxpaSfhjrx48gKX7pA-coao2wsUhtSvfPwtHt0Fn8fJ-Mt-LOqhaG0ypVMrAW1mWq6I--gaxBGIuIi67g2LWLU63-dXfg0QYoiratxGg2JHNurJbpv1ZdBD3G9H0X9bz8Oj_x2woCvecznvoiTREuudZIKl3V1FndxUxH5EUjngXNSZ85Ki2aIMyKSKrOo8aQIlHFSJQHH796D-4LzjNIJxVhc3-8EIkJ2anLthUiyjl5c2kX1mYs05pta8IZpezND88GinMmrpZxM_lF__cfwqLVb2UFDaE9gy5ZPYWfYRuafwfJQTjRKh7IoGbWy9ussO2vYiNJmjGWyNOyAysap3J8iUCU7oYSlivXqSkk20OgH1GD1LWVRv47wYWoqhtCjpgNsxX4W83M2LH7TcAv7HM7u5MhfwHY5Le0rYC5WCTrwzgXcxmhpSYnWHWpX7kJ0tNLEg0-rQ8512_GcBm9McvR8CCV5g5K8RokH-2voWdPp4z9weyt85S2_V_k1dXrwfr2MnErhF1na6YJgQiFEFiapBy8b9K5_xNERp9HfHqQbiF8DUBfwzZWyOK-7gaNMzSi468HHNY3cuoHd2zfwDnaQsfKTwenxa3gYoU1HwbMw24Pt-eXCvkEbbK7e1sTO4Nddc9dfPzZMwA
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lj9MwEB4tXQm48F4ILMhIwAWlTWK7To7VwmpBdNUD1S6nyE9aUdxqm2iBX884SSvKCsSFWyJP5NfY_iYz_gbghTFCUaVknKeaxyyzIpYuUbGyxijLRG7TcN95fDo8mbL35_x8D842d2EQMdoKR7u-sHVH_7daLKVZDzaJospuSAcr4wYpQ7zMggWPZnla4JxnCYu_rvxsqfsocA32hxxBeg_2p6eT0aeQai4d5tiynLVh8ELwYtBVR0XO6O4BdQV1Xg2evFH7lfx-KReLX06m49vwbdOnNiDlS7-uVF__-I3u8T90-g7c6tAsGbWf3YU96-_B9XHnr78Pl0dyoXHP8HNPAsF13MTeWUMmIZjGWCK9IaNwmTyQAAS_lCcfQhjTmrxp7k-Sdxqtg0as-Xc5b14n-LA0a4LSk5YXdk3O5tWMjOefQ8oL-wCmx28_Hp3EXaqHWFNGq1gwzrWkWvNcuGKoCzZE7cqCQYcbTuKc1IWz0iIedEZkUhUWoYcUiTJOKp7QA-j5pbePgDimOJr1ziXUMsRfUiLmwzOXuhTNr5xH8Hozv6XueNBDOo5FifZQ0IaynYey0YYIXm6lVy3_xx_kDjeqUna7wLrExqeZyKgoIni-Lcb1G5wy0ttlHWRSIUSR8jyCh61mbSuiaJ6HhOAR5Ds6txUI3OC7JX4-azjCcactgss3gldb9fxrBx7_q-ATuBk0L3jU0uIQetVFbZ8iMKvUs26R_QRZ8D_E
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Calcitonin+Gene-Related+Peptide+and+Adrenomedullin+Levels+During+Ictal+and+Interictal+Periods+in+Patients+With+Migraine&rft.jtitle=Cur%C4%93us+%28Palo+Alto%2C+CA%29&rft.au=Neyal%2C+Abdurrahman&rft.au=Ekmekyapar+F%C4%B1rat%2C+Yasemin&rft.au=%C3%87ekmen%2C+Mustafa+B&rft.au=K%C4%B1l%C4%B1%C3%A7parlar+Cengiz%2C+Emine&rft.date=2023-04-19&rft.issn=2168-8184&rft.eissn=2168-8184&rft.volume=15&rft.issue=4&rft.spage=e37843&rft_id=info:doi/10.7759%2Fcureus.37843&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2168-8184&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2168-8184&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2168-8184&client=summon